Share Price and Basic Stock Data
Last Updated: November 6, 2025, 8:16 am
| PEG Ratio | -185.92 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Ambani Organics Ltd operates in the organic chemicals sector, with its current market capitalization reported at ₹107 Cr. The company’s share price stood at ₹140, reflecting a P/E ratio of 5,352, which is significantly higher than typical sector averages, indicating potential overvaluation concerns. The company’s revenue from operations has shown fluctuations over the years; it recorded sales of ₹132 Cr in FY 2023, which rose to ₹136 Cr in FY 2024 and is projected to reach ₹193 Cr by FY 2025. The quarterly sales data indicates a peak in March 2025 at ₹112 Cr, suggesting a positive trend. However, the overall sales growth from ₹52 Cr in FY 2017 to ₹136 Cr in FY 2024 illustrates volatility rather than steady growth, with sales peaking at ₹125 Cr in FY 2022 before a slight dip. This inconsistency may hinder investor confidence despite the company’s efforts to stabilize its revenue streams.
Profitability and Efficiency Metrics
The profitability metrics for Ambani Organics Ltd reveal a challenging landscape, with a reported net profit of -₹1 Cr in FY 2023, showing a decline from ₹2 Cr in FY 2022. The operating profit margin (OPM) reported at 6% in FY 2023 reflects a slight recovery from lower margins in previous years, but the overall profitability remains under pressure. The company has recorded a return on equity (ROE) of 0.04% and a return on capital employed (ROCE) of 7.12%, both of which are considerably low compared to industry standards. The interest coverage ratio (ICR) of 3.51x indicates that the company can cover its interest obligations comfortably, yet the negative net profit margin of -0.44% in FY 2025 underscores ongoing operational challenges. The cash conversion cycle standing at -29 days further highlights operational efficiency, but the decline in profitability raises questions about the sustainability of these efficiency gains.
Balance Sheet Strength and Financial Ratios
Ambani Organics Ltd’s balance sheet shows a total debt of ₹60 Cr against reserves of ₹44 Cr, resulting in a total debt to equity ratio of 1.05, suggesting a leveraged position. The reported current ratio of 1.01 and quick ratio of 0.67 indicate that while the company can meet short-term liabilities, liquidity remains tight. The book value per share stood at ₹66.82, reflecting a price-to-book value (P/BV) ratio of 1.73x, which is relatively high compared to typical sector ranges. The company has also reported fixed assets growing from ₹12 Cr in FY 2017 to ₹77 Cr in FY 2025, signaling expansion in its operational capacity. However, the interest coverage ratio of 3.51x, although adequate, could become concerning if profitability does not improve. Overall, while the company has made strides in asset growth, the high leverage poses risks, particularly in an uncertain economic environment.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Ambani Organics Ltd reflects a majority holding by promoters at 61.25%, which may provide stability but also raises concerns about limited public participation. The public shareholding stands at 38.75%, indicating a relatively concentrated ownership structure. The number of shareholders has fluctuated, with 281 reported as of March 2025, down from a peak of 293 in November 2024. This decline in shareholders could signal waning investor interest or confidence. Additionally, the lack of foreign institutional investors (FIIs) and domestic institutional investors (DIIs) highlights a potential gap in institutional support. While the promoter stake indicates a level of commitment, the overall shareholder dynamics suggest a need for increased transparency and engagement to bolster investor confidence and attract broader market participation.
Outlook, Risks, and Final Insight
Ambani Organics Ltd faces a mixed outlook, with potential growth opportunities tempered by significant risks. The company’s revenue trajectory shows promise with expected sales growth to ₹193 Cr in FY 2025, but the profitability challenges, particularly the negative net profit margin, could hinder sustainable growth. Key strengths include a robust interest coverage ratio and efficient cash conversion cycle, which may support operational stability. However, risks such as high leverage, potential operational inefficiencies, and a concentrated shareholding structure could impact future performance. For investors, the company presents a speculative opportunity, contingent on improvements in profitability and a more diversified shareholder base. Should the company manage to enhance its operational efficiency and stabilize profits, it may regain investor confidence, leading to a more favorable market perception.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Ambani Organics Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujchem Distillers India Ltd | 123 Cr. | 345 | 456/255 | 127 | 390 | 0.03 % | 0.21 % | 0.09 % | 1.00 |
| Elantas Beck India Ltd | 7,920 Cr. | 9,990 | 14,250/8,150 | 57.3 | 1,177 | 0.08 % | 23.0 % | 17.4 % | 10.0 |
| Crestchem Ltd | 37.5 Cr. | 125 | 329/114 | 15.1 | 24.9 | 0.80 % | 59.9 % | 44.1 % | 10.0 |
| Chemiesynth (Vapi) Ltd | 11.6 Cr. | 37.6 | 37.6/35.8 | 35.8 | 0.00 % | 3.10 % | 0.99 % | 10.0 | |
| ARCL Organics Ltd | 256 Cr. | 320 | 385/163 | 19.8 | 94.6 | 0.00 % | 20.4 % | 16.8 % | 10.0 |
| Industry Average | 4,377.14 Cr | 1,665.31 | 405.64 | 330.79 | 0.36% | 14.71% | 10.69% | 7.56 |
Quarterly Result
| Metric | Mar 2019 | Sep 2019 | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 42 | 38 | 36 | 26 | 61 | 67 | 59 | 67 | 66 | 62 | 74 | 82 | 112 |
| Expenses | 39 | 35 | 33 | 24 | 57 | 64 | 55 | 64 | 61 | 58 | 74 | 77 | 106 |
| Operating Profit | 3 | 3 | 3 | 2 | 4 | 3 | 4 | 4 | 5 | 5 | 0 | 4 | 6 |
| OPM % | 8% | 7% | 8% | 9% | 7% | 5% | 7% | 5% | 7% | 8% | 0% | 5% | 6% |
| Other Income | -0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 5 | 0 | 0 |
| Interest | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 2 | 2 | 3 | 4 | 4 | 3 |
| Depreciation | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
| Profit before tax | 1 | 1 | 1 | 0 | 2 | 1 | 2 | 1 | 2 | 0 | -0 | -1 | 2 |
| Tax % | 22% | 43% | 21% | 24% | 38% | 32% | 26% | 26% | 41% | 63% | -5,960% | 33% | 47% |
| Net Profit | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 3 | -2 | 1 |
| EPS in Rs | 1.99 | 1.14 | 1.59 | 0.71 | 2.64 | 1.46 | 1.97 | 1.35 | 1.73 | 0.16 | 4.15 | -2.52 | 1.21 |
Last Updated: August 5, 2025, 3:16 pm
Below is a detailed analysis of the quarterly data for Ambani Organics Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 112.00 Cr.. The value appears strong and on an upward trend. It has increased from 82.00 Cr. (Sep 2024) to 112.00 Cr., marking an increase of 30.00 Cr..
- For Expenses, as of Mar 2025, the value is 106.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 77.00 Cr. (Sep 2024) to 106.00 Cr., marking an increase of 29.00 Cr..
- For Operating Profit, as of Mar 2025, the value is 6.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Sep 2024) to 6.00 Cr., marking an increase of 2.00 Cr..
- For OPM %, as of Mar 2025, the value is 6.00%. The value appears strong and on an upward trend. It has increased from 5.00% (Sep 2024) to 6.00%, marking an increase of 1.00%.
- For Other Income, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
- For Interest, as of Mar 2025, the value is 3.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.00 Cr. (Sep 2024) to 3.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Mar 2025, the value is 2.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.00 Cr. (Sep 2024) to 2.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Mar 2025, the value is 2.00 Cr.. The value appears strong and on an upward trend. It has increased from -1.00 Cr. (Sep 2024) to 2.00 Cr., marking an increase of 3.00 Cr..
- For Tax %, as of Mar 2025, the value is 47.00%. The value appears to be increasing, which may not be favorable. It has increased from 33.00% (Sep 2024) to 47.00%, marking an increase of 14.00%.
- For Net Profit, as of Mar 2025, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from -2.00 Cr. (Sep 2024) to 1.00 Cr., marking an increase of 3.00 Cr..
- For EPS in Rs, as of Mar 2025, the value is 1.21. The value appears strong and on an upward trend. It has increased from -2.52 (Sep 2024) to 1.21, marking an increase of 3.73.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 5:44 am
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 52 | 65 | 79 | 73 | 87 | 125 | 132 | 136 | 193 |
| Expenses | 49 | 60 | 74 | 68 | 81 | 118 | 124 | 131 | 183 |
| Operating Profit | 3 | 5 | 6 | 5 | 6 | 6 | 8 | 5 | 9 |
| OPM % | 6% | 7% | 7% | 7% | 7% | 5% | 6% | 3% | 5% |
| Other Income | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 5 | 2 |
| Interest | 2 | 2 | 3 | 3 | 3 | 3 | 4 | 7 | 8 |
| Depreciation | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 |
| Profit before tax | 1 | 2 | 2 | 2 | 3 | 3 | 3 | 0 | 0 |
| Tax % | 32% | 17% | 28% | 39% | 35% | 28% | 35% | -1,116% | 300% |
| Net Profit | 1 | 2 | 2 | 1 | 2 | 2 | 2 | 3 | -1 |
| EPS in Rs | 2.10 | 4.64 | 3.41 | 2.72 | 3.35 | 3.12 | 3.08 | 4.31 | -1.11 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 100.00% | 0.00% | -50.00% | 100.00% | 0.00% | 0.00% | 50.00% | -133.33% |
| Change in YoY Net Profit Growth (%) | 0.00% | -100.00% | -50.00% | 150.00% | -100.00% | 0.00% | 50.00% | -183.33% |
Ambani Organics Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2017-2018 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 22% |
| 3 Years: | 16% |
| TTM: | 42% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 19% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 22% |
| 3 Years: | 21% |
| 1 Year: | 43% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 2% |
| 3 Years: | -1% |
| Last Year: | -3% |
Last Updated: September 4, 2025, 11:00 pm
Balance Sheet
Last Updated: October 10, 2025, 1:37 pm
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4 | 4 | 5 | 5 | 5 | 6 | 6 | 7 | 8 |
| Reserves | 0 | 2 | 10 | 12 | 13 | 24 | 26 | 39 | 44 |
| Borrowings | 13 | 16 | 15 | 20 | 34 | 53 | 52 | 61 | 60 |
| Other Liabilities | 22 | 26 | 31 | 26 | 25 | 29 | 54 | 68 | 97 |
| Total Liabilities | 38 | 48 | 61 | 62 | 78 | 112 | 137 | 176 | 208 |
| Fixed Assets | 12 | 13 | 13 | 15 | 21 | 22 | 21 | 59 | 77 |
| CWIP | 0 | 0 | 0 | 2 | 0 | 9 | 47 | 8 | 7 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 26 | 35 | 48 | 46 | 56 | 80 | 69 | 109 | 124 |
| Total Assets | 38 | 48 | 61 | 62 | 78 | 112 | 137 | 176 | 208 |
Below is a detailed analysis of the balance sheet data for Ambani Organics Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 8.00 Cr.. The value appears strong and on an upward trend. It has increased from 7.00 Cr. (Mar 2024) to 8.00 Cr., marking an increase of 1.00 Cr..
- For Reserves, as of Mar 2025, the value is 44.00 Cr.. The value appears strong and on an upward trend. It has increased from 39.00 Cr. (Mar 2024) to 44.00 Cr., marking an increase of 5.00 Cr..
- For Borrowings, as of Mar 2025, the value is 60.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 61.00 Cr. (Mar 2024) to 60.00 Cr., marking a decrease of 1.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 97.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 68.00 Cr. (Mar 2024) to 97.00 Cr., marking an increase of 29.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 208.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 176.00 Cr. (Mar 2024) to 208.00 Cr., marking an increase of 32.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 77.00 Cr.. The value appears strong and on an upward trend. It has increased from 59.00 Cr. (Mar 2024) to 77.00 Cr., marking an increase of 18.00 Cr..
- For CWIP, as of Mar 2025, the value is 7.00 Cr.. The value appears to be declining and may need further review. It has decreased from 8.00 Cr. (Mar 2024) to 7.00 Cr., marking a decrease of 1.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 124.00 Cr.. The value appears strong and on an upward trend. It has increased from 109.00 Cr. (Mar 2024) to 124.00 Cr., marking an increase of 15.00 Cr..
- For Total Assets, as of Mar 2025, the value is 208.00 Cr.. The value appears strong and on an upward trend. It has increased from 176.00 Cr. (Mar 2024) to 208.00 Cr., marking an increase of 32.00 Cr..
However, the Borrowings (60.00 Cr.) are higher than the Reserves (44.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -10.00 | -11.00 | -9.00 | -15.00 | -28.00 | -47.00 | -44.00 | -56.00 | -51.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 112 | 103 | 104 | 117 | 127 | 94 | 78 | 72 | 80 |
| Inventory Days | 53 | 70 | 95 | 102 | 92 | 75 | 77 | 100 | 103 |
| Days Payable | 129 | 131 | 134 | 100 | 81 | 63 | 142 | 194 | 213 |
| Cash Conversion Cycle | 35 | 42 | 65 | 118 | 138 | 105 | 13 | -22 | -29 |
| Working Capital Days | -8 | 3 | 31 | 42 | 36 | 17 | -14 | 20 | -29 |
| ROCE % | 22% | 20% | 15% | 12% | 9% | 9% | 2% | 7% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -2.11 | -12.80 | 1.07 | 3.06 | 3.35 |
| Diluted EPS (Rs.) | -2.10 | -12.80 | 1.07 | 3.06 | 3.35 |
| Cash EPS (Rs.) | 9.04 | 8.32 | 5.34 | 5.32 | 5.38 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 66.82 | 65.64 | 49.70 | 47.69 | 36.49 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 66.82 | 65.64 | 49.70 | 47.69 | 36.49 |
| Revenue From Operations / Share (Rs.) | 253.21 | 192.96 | 206.42 | 195.94 | 170.65 |
| PBDIT / Share (Rs.) | 14.10 | 7.23 | 13.51 | 11.51 | 12.99 |
| PBIT / Share (Rs.) | 3.94 | 3.23 | 11.24 | 9.31 | 10.96 |
| PBT / Share (Rs.) | -0.07 | -10.05 | 4.69 | 4.36 | 5.14 |
| Net Profit / Share (Rs.) | -1.12 | 4.31 | 3.07 | 3.13 | 3.35 |
| NP After MI And SOA / Share (Rs.) | -1.12 | 4.31 | 3.07 | 3.13 | 3.35 |
| PBDIT Margin (%) | 5.56 | 3.74 | 6.54 | 5.87 | 7.61 |
| PBIT Margin (%) | 1.55 | 1.67 | 5.44 | 4.75 | 6.42 |
| PBT Margin (%) | -0.02 | -5.20 | 2.27 | 2.22 | 3.01 |
| Net Profit Margin (%) | -0.44 | 2.23 | 1.48 | 1.59 | 1.96 |
| NP After MI And SOA Margin (%) | -0.44 | 2.23 | 1.48 | 1.59 | 1.96 |
| Return on Networth / Equity (%) | -1.67 | 6.56 | 6.18 | 6.55 | 9.18 |
| Return on Capital Employeed (%) | 3.50 | 2.74 | 10.23 | 10.50 | 16.54 |
| Return On Assets (%) | -0.41 | 1.73 | 1.43 | 1.79 | 2.18 |
| Long Term Debt / Equity (X) | 0.42 | 0.50 | 0.73 | 0.37 | 0.32 |
| Total Debt / Equity (X) | 1.05 | 1.19 | 2.09 | 1.54 | 1.70 |
| Asset Turnover Ratio (%) | 1.01 | 0.87 | 1.06 | 1.33 | 1.23 |
| Current Ratio (X) | 1.01 | 1.15 | 1.01 | 1.30 | 1.27 |
| Quick Ratio (X) | 0.67 | 0.83 | 0.66 | 0.91 | 0.86 |
| Inventory Turnover Ratio (X) | 4.46 | 4.29 | 5.17 | 5.06 | 4.34 |
| Interest Coverage Ratio (X) | 3.51 | 0.75 | 2.08 | 2.32 | 2.19 |
| Interest Coverage Ratio (Post Tax) (X) | 0.56 | 0.75 | 1.48 | 1.63 | 1.55 |
| Enterprise Value (Cr.) | 131.77 | 126.46 | 118.61 | 112.99 | 51.85 |
| EV / Net Operating Revenue (X) | 0.67 | 0.92 | 0.89 | 0.89 | 0.59 |
| EV / EBITDA (X) | 12.20 | 24.77 | 13.65 | 15.26 | 7.86 |
| MarketCap / Net Operating Revenue (X) | 0.45 | 0.53 | 0.39 | 0.56 | 0.26 |
| Price / BV (X) | 1.73 | 1.57 | 1.63 | 2.31 | 1.26 |
| Price / Net Operating Revenue (X) | 0.45 | 0.53 | 0.39 | 0.56 | 0.26 |
| EarningsYield | -0.01 | 0.04 | 0.03 | 0.02 | 0.07 |
After reviewing the key financial ratios for Ambani Organics Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -2.11. This value is below the healthy minimum of 5. It has increased from -12.80 (Mar 24) to -2.11, marking an increase of 10.69.
- For Diluted EPS (Rs.), as of Mar 25, the value is -2.10. This value is below the healthy minimum of 5. It has increased from -12.80 (Mar 24) to -2.10, marking an increase of 10.70.
- For Cash EPS (Rs.), as of Mar 25, the value is 9.04. This value is within the healthy range. It has increased from 8.32 (Mar 24) to 9.04, marking an increase of 0.72.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 66.82. It has increased from 65.64 (Mar 24) to 66.82, marking an increase of 1.18.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 66.82. It has increased from 65.64 (Mar 24) to 66.82, marking an increase of 1.18.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 253.21. It has increased from 192.96 (Mar 24) to 253.21, marking an increase of 60.25.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 14.10. This value is within the healthy range. It has increased from 7.23 (Mar 24) to 14.10, marking an increase of 6.87.
- For PBIT / Share (Rs.), as of Mar 25, the value is 3.94. This value is within the healthy range. It has increased from 3.23 (Mar 24) to 3.94, marking an increase of 0.71.
- For PBT / Share (Rs.), as of Mar 25, the value is -0.07. This value is below the healthy minimum of 0. It has increased from -10.05 (Mar 24) to -0.07, marking an increase of 9.98.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -1.12. This value is below the healthy minimum of 2. It has decreased from 4.31 (Mar 24) to -1.12, marking a decrease of 5.43.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -1.12. This value is below the healthy minimum of 2. It has decreased from 4.31 (Mar 24) to -1.12, marking a decrease of 5.43.
- For PBDIT Margin (%), as of Mar 25, the value is 5.56. This value is below the healthy minimum of 10. It has increased from 3.74 (Mar 24) to 5.56, marking an increase of 1.82.
- For PBIT Margin (%), as of Mar 25, the value is 1.55. This value is below the healthy minimum of 10. It has decreased from 1.67 (Mar 24) to 1.55, marking a decrease of 0.12.
- For PBT Margin (%), as of Mar 25, the value is -0.02. This value is below the healthy minimum of 10. It has increased from -5.20 (Mar 24) to -0.02, marking an increase of 5.18.
- For Net Profit Margin (%), as of Mar 25, the value is -0.44. This value is below the healthy minimum of 5. It has decreased from 2.23 (Mar 24) to -0.44, marking a decrease of 2.67.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -0.44. This value is below the healthy minimum of 8. It has decreased from 2.23 (Mar 24) to -0.44, marking a decrease of 2.67.
- For Return on Networth / Equity (%), as of Mar 25, the value is -1.67. This value is below the healthy minimum of 15. It has decreased from 6.56 (Mar 24) to -1.67, marking a decrease of 8.23.
- For Return on Capital Employeed (%), as of Mar 25, the value is 3.50. This value is below the healthy minimum of 10. It has increased from 2.74 (Mar 24) to 3.50, marking an increase of 0.76.
- For Return On Assets (%), as of Mar 25, the value is -0.41. This value is below the healthy minimum of 5. It has decreased from 1.73 (Mar 24) to -0.41, marking a decrease of 2.14.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.42. This value is within the healthy range. It has decreased from 0.50 (Mar 24) to 0.42, marking a decrease of 0.08.
- For Total Debt / Equity (X), as of Mar 25, the value is 1.05. This value exceeds the healthy maximum of 1. It has decreased from 1.19 (Mar 24) to 1.05, marking a decrease of 0.14.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.01. It has increased from 0.87 (Mar 24) to 1.01, marking an increase of 0.14.
- For Current Ratio (X), as of Mar 25, the value is 1.01. This value is below the healthy minimum of 1.5. It has decreased from 1.15 (Mar 24) to 1.01, marking a decrease of 0.14.
- For Quick Ratio (X), as of Mar 25, the value is 0.67. This value is below the healthy minimum of 1. It has decreased from 0.83 (Mar 24) to 0.67, marking a decrease of 0.16.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.46. This value is within the healthy range. It has increased from 4.29 (Mar 24) to 4.46, marking an increase of 0.17.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 3.51. This value is within the healthy range. It has increased from 0.75 (Mar 24) to 3.51, marking an increase of 2.76.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.56. This value is below the healthy minimum of 3. It has decreased from 0.75 (Mar 24) to 0.56, marking a decrease of 0.19.
- For Enterprise Value (Cr.), as of Mar 25, the value is 131.77. It has increased from 126.46 (Mar 24) to 131.77, marking an increase of 5.31.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.67. This value is below the healthy minimum of 1. It has decreased from 0.92 (Mar 24) to 0.67, marking a decrease of 0.25.
- For EV / EBITDA (X), as of Mar 25, the value is 12.20. This value is within the healthy range. It has decreased from 24.77 (Mar 24) to 12.20, marking a decrease of 12.57.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.45. This value is below the healthy minimum of 1. It has decreased from 0.53 (Mar 24) to 0.45, marking a decrease of 0.08.
- For Price / BV (X), as of Mar 25, the value is 1.73. This value is within the healthy range. It has increased from 1.57 (Mar 24) to 1.73, marking an increase of 0.16.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.45. This value is below the healthy minimum of 1. It has decreased from 0.53 (Mar 24) to 0.45, marking a decrease of 0.08.
- For EarningsYield, as of Mar 25, the value is -0.01. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 24) to -0.01, marking a decrease of 0.05.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Ambani Organics Ltd:
- Net Profit Margin: -0.44%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 3.5% (Industry Average ROCE: 14.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -1.67% (Industry Average ROE: 10.69%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0.56
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.67
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 5 (Industry average Stock P/E: 405.64)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.05
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -0.44%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Others | N-44, MIDC Tarapur, Boisar, Thane Maharashtra 401506 | info@ambaniorganics.com http://www.ambaniorganics.com |
| Management | |
|---|---|
| Name | Position Held |
| Mrs. Apooni R Shah | Chairman & Wholetime Director |
| Mr. Rakesh H Shah | Managing Director |
| Mr. Bhavin Jitendra Patel | Ind. Non-Executive Director |
| Mr. Neerajkumar A Pandey | Ind. Non-Executive Director |
| Mr. Sanjay N Mehta | Independent Director |
| Dr. Prakash A Mahanwar | Independent Director |
FAQ
What is the intrinsic value of Ambani Organics Ltd?
Ambani Organics Ltd's intrinsic value (as of 09 November 2025) is 116.69 which is 16.65% lower the current market price of 140.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 107 Cr. market cap, FY2025-2026 high/low of 150/96.2, reserves of ₹44 Cr, and liabilities of 208 Cr.
What is the Market Cap of Ambani Organics Ltd?
The Market Cap of Ambani Organics Ltd is 107 Cr..
What is the current Stock Price of Ambani Organics Ltd as on 09 November 2025?
The current stock price of Ambani Organics Ltd as on 09 November 2025 is 140.
What is the High / Low of Ambani Organics Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Ambani Organics Ltd stocks is 150/96.2.
What is the Stock P/E of Ambani Organics Ltd?
The Stock P/E of Ambani Organics Ltd is 5,352.
What is the Book Value of Ambani Organics Ltd?
The Book Value of Ambani Organics Ltd is 66.8.
What is the Dividend Yield of Ambani Organics Ltd?
The Dividend Yield of Ambani Organics Ltd is 0.00 %.
What is the ROCE of Ambani Organics Ltd?
The ROCE of Ambani Organics Ltd is 7.12 %.
What is the ROE of Ambani Organics Ltd?
The ROE of Ambani Organics Ltd is 0.04 %.
What is the Face Value of Ambani Organics Ltd?
The Face Value of Ambani Organics Ltd is 10.0.